News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Andromed (CC:AD) Release: Positive Results with Androflo(TM)



10/19/2005 5:11:01 PM

Andromed Inc. (TSX Venture Exchange: AD), an innovative medical technology company, announces that the results from a clinical study on its non-invasive respiratory monitor, Androflo(TM), were positive. Androflo(TM) is a non-invasive system that converts tracheal sounds detected on a patient's throat using Andromed's Androsonix(TM) acoustic biosensor into estimates of respiratory rate (RR) and other ventilation parameters.

Read at Canada NewsWire


comments powered by Disqus
Andromed
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES